Lanean...
Therapeutic Challenges for Cisplatin-Resistant Ovarian Germ Cell Tumors
The majority of patients with advanced ovarian germ cell cancer are treated by cisplatin-based chemotherapy. Despite adequate first-line treatment, nearly one third of patients relapse and almost half develop cisplatin-resistant disease, which is often fatal. The treatment of cisplatin-resistant dis...
Gorde:
| Egile Nagusiak: | , , , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
MDPI AG
2019-10-01
|
| Saila: | Cancers |
| Gaiak: | |
| Sarrera elektronikoa: | https://www.mdpi.com/2072-6694/11/10/1584 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|